Prioritising collaboration over self-interest is the way to learn about who gets the best from which treatments in the complex world of advanced prostate cancer. Silke Gillessen talked to Simon Crompton about how she is [more]
The main common feature of cancer cells is their ability to escape to homeostatic regulation mechanisms of living. In a sense giving them immortality, causing in the absence of treatment the death of the organism, [more]
A new model of active surveillance (AS) for patients with low-risk prostate cancer proved to be effective in helping clinicians to appropriately select and follow patients preventing the risk of overtreatment, according to the results [more]
ESO, CNIO and NRCO Conference on Familial Cancer 19/05/2016 – 20/05/2016, Madrid, Spain Chairs: R. Eeles, UK – W.D. Foulkes, CA – M. Robledo, ES – H. Vasen, NL The ESO, CNIO and NRCO Conference [more]
People with cancer need their care managed by a team of specialists who work together and learn and improve together. Simon Crompton reports on efforts to achieve such a collaborative approach in delivering prostate cancer [more]
This egrandround was first presented by Caroline Moore, from University College Hospital London, as a live webcast for the European School of Oncology. It is edited by Susan Mayor. The webcast of this and other [more]
Recent evolution of prostate cancer treatment reflects technological arms races driven by economic incentives rather than high-quality evidence as exemplified by proton-beam radiation, recently found markedly inferior to far less expensive alternatives. Another study [more]
Download full article
Selected reports edited by Janet Fricker Download full article